USDA to invest $100 million in bird flu research

EditorLouis Juricic
Published 03/20/2025, 10:55 AM
USDA to invest $100 million in bird flu research

Investing.com -- The U.S. Department of Agriculture (USDA) announced plans on Thursday to invest up to $100 million in projects aimed at researching therapies and potential vaccine candidates to help combat bird flu. The funding will be made available to a range of entities including for-profit organizations, such as vaccine and therapy manufacturers, as well as states, universities and other eligible bodies.

Earlier this year in February, Agriculture Secretary Brooke Rollins declared that the U.S. would invest up to $1 billion to fight the spread of bird flu and ramp up egg imports in a bid to reduce high prices.

The USDA is specifically looking for vaccine candidates that are well matched to the currently circulating variants of the bird flu virus. The agency is also seeking solutions that require a hands-off delivery method for protecting poultry, such as chickens and turkeys.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.